WO1998005270A1 - Tubular prosthesis having improved expansion and imaging characteristics - Google Patents

Tubular prosthesis having improved expansion and imaging characteristics Download PDF

Info

Publication number
WO1998005270A1
WO1998005270A1 PCT/US1997/012833 US9712833W WO9805270A1 WO 1998005270 A1 WO1998005270 A1 WO 1998005270A1 US 9712833 W US9712833 W US 9712833W WO 9805270 A1 WO9805270 A1 WO 9805270A1
Authority
WO
WIPO (PCT)
Prior art keywords
prosthesis
hinge regions
struts
hinge
weakened
Prior art date
Application number
PCT/US1997/012833
Other languages
French (fr)
Inventor
Enrique J. Klein
Anthony P. Widdershoven
Original Assignee
Localmed, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Localmed, Inc. filed Critical Localmed, Inc.
Priority to JP10507944A priority Critical patent/JP2000516486A/en
Priority to AU38089/97A priority patent/AU3808997A/en
Publication of WO1998005270A1 publication Critical patent/WO1998005270A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/36Image-producing devices or illumination devices not otherwise provided for
    • A61B90/37Surgical systems with images on a monitor during operation
    • A61B2090/376Surgical systems with images on a monitor during operation using X-rays, e.g. fluoroscopy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91508Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91516Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91566Adjacent bands being connected to each other connected trough to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped

Definitions

  • the present invention relates generally to the structure of radially expansible lumenal prostheses, including stents and grafts. More particularly, the present invention relates to the structure of prostheses having controlled expansion characteristics and controlled radiopacity.
  • Lumenal prostheses are provided for a variety of medical purposes.
  • lumenal stents can be placed in various body lumens, such as blood vessels, the ureter, the urethra, the biliary tract, and the gastrointestinal tract, for maintaining patency.
  • Such stents are particularly useful for placement in pre-dilated atherosclerotic sites in blood vessels.
  • Lumenal grafts can be placed in blood vessels to provide support in diseased regions, such as abdominal and other aneurysms .
  • Lumenal stents and other prostheses are available in a wide variety of configurations, including helical coils, rolled tubular sleeves, serpentine rings, zig-zag rings, expansible box constructions, and the like. Each of these configurations may also be provided as either a self -expanding prothesis, typically being formed from an alloy displaying superelastic and/or shape memory properties, such as nickel titanium, or as a malleable prosthesis which is deployed by internal expansion of a balloon to radially expand the prosthesis structure.
  • a self -expanding prothesis typically being formed from an alloy displaying superelastic and/or shape memory properties, such as nickel titanium, or as a malleable prosthesis which is deployed by internal expansion of a balloon to radially expand the prosthesis structure.
  • serpentine, zig-zag, and box stents which comprise a plurality of strut elements joined by malleable or plastically deformable hinge regions .
  • Such prostheses are expanded by applying a radially outward internal force within a lumen of the prosthesis, typically by expanding a balloon catheter --,
  • a serpentine stent 10 comprises struts 12 joined by hinge regions 14.
  • the particular stent 12 illustrated includes a total of twelve struts 12 joined by twelve hinge regions 14, with six hinge regions being disposed at each end of the stent .
  • each of the hinge regions 12 will open simultaneously at an equal rate so that the angles between adjacent struts 12 remain equal at all times during expansion.
  • certain internal surfaces of the stent may experience greater tangential forces than experienced by other surfaces, causing an uneven expansion.
  • Figs. 2 and 3 illustrate stent 10 in a "rolled-out" view.
  • Fig. 2 shows the stent in its non-expanded configuration prior to deployment.
  • Fig. 3 shows the stent in a typical configuration after partial opening as a result of internal balloon expansion.
  • the uneven pattern of Fig. 3 will result when hinge regions 14a are mechanically stronger than hinge regions 14b, resulting in hinge regions 14b opening more readily than hinge regions 14a.
  • a similarly uneven expansion pattern may also result from non-uniform tangential forces between the balloon and the interior surfaces of the stent, or from a combination of these forces and differences in the strengths of the hinge regions.
  • a separate problem in stent construction and deployment relates to the ability to detect the stent fluoroscopically during the deployment procedure.
  • Stents composed of nickel titanium alloys and other radiopaque materials can be readily observed fluoroscopically if the cross-sections of their components are sufficiently large. If the stent is highly radiopaque, however, the stent itself, even in its expanded condition, can interfere with subsequent fluoroscopic examination of the treated area to confirm that the body lumen remains patent.
  • stainless steel and other common stent materials are generally radiolucent, i.e. they permit fluoroscopic examination therethrough. Such stents are advantageous since they do not prevent subsequent fluoroscopic examination of the treated region of the body lumen. They are, however, much more difficult to position accurately and usually require attachment of a separate radiopaque marker (s).
  • EP 662 307 describes an expansible stent having serpentine elements having regions with varying degrees of curvature to provide controlled expansion characteristics.
  • EP 679 372 describes an expansible stent which is plated with a radiopaque material at each end to enhance fluoroscopic visibility.
  • the present invention provides improved radially expansible tubular prostheses and methods for their endolu enal placement within body lumens, particularly blood vessels.
  • the prostheses may be in the form of stents, intended for maintaining lumenal patency, or may be in the form of grafts, intended for protecting or enhancing the strength of the lumenal wall .
  • the prostheses of the present invention will be plastically deformable or malleable and radially expansible by the application of a radially outward internal force, typically applied by a balloon catheter expanded within a lumen of the prosthesis.
  • the radially expansible tubular prosthesis comprises at least one serpentine, zig-zag, or box element having struts joined together by hinge regions which yieldably open in response to a radially outwardly directed internal force. Selected ones of the hinge regions are weakened relative to others so that the weakened hinge regions open before the other (non-weakened or strengthened) hinge regions. Usually, it will sufficient to provide only two "groups" of hinge regions, (i.e., one group which is weakened relative to the other) but it will also be possible to provide three, four, or more different groups of hinge regions, each group programmed to open in response to successively greater expansion forces.
  • the stent By 5 properly distributing the weakened and non-weakened hinge regions about the tubular prosthesis, usually but not necessarily distributing the weakened regions evenly about the periphery, the stent can be "programmed" to open in a generally uniform manner. That is, opening of the stent will not be confined to a limited region in one portion or on one side of the stent.
  • Exemplary serpentine (or zig-zag) elements will usually comprise a plurality of struts having substantially equal lengths joined together in a reversing pattern.
  • the reversing pattern will typically comprise repeating S- shaped hinge regions or repeating Z-shaped hinge regions. The latter pattern is commonly referred to a zig-zag stent.
  • Box elements will typically comprise a plurality of struts and hinge regions joined in a rectangular pattern, where the rectangle opens to a diamond or lozenge pattern as the prosthesis is expanded.
  • the box elements each include four struts joined by four hinges.
  • the struts are arranged in two colinear pairs, each with one hinge region therebetween.
  • the two pairs of struts are then joined together in parallel, with a single hinge at each end.
  • Box elements are attached to each other at or near the hinge regions between the colinear struts, with the expansion force being applied through these hinge regions. In this way, the box elements open into the diamond or lozenge pattern as the prosthesis is radially expanded.
  • the weakened hinge regions are disposed between the ends of adjacent pairs of parallel struts.
  • the hinge region will act as the center of deflection (or in some cases centers as described in detail below) about which the two adjacent struts open as the prosthesis is expanded.
  • the weakened hinge regions may be disposed between adjacent ends of pairs of colinear struts. In such cases, the struts will usually be initially straight
  • the serpentine or zig-zag structures will typically comprise a plurality of parallel, adjacent struts which are joined by hinge regions between pairs of struts on alternating sides of the prosthesis element.
  • weakened hinge regions By peripherally disposing weakened hinge regions evenly about the tubular prosthesis (as described in much greater detail below) , a generally uniform pattern of opening of the prosthesis can be assured.
  • Box elements will generally comprise at least four struts, with the inner ends of the struts being joined in a colinear manner and the outside ends of the struts being joined in a parallel manner. Such a hinge pattern will provide opening of the original rectangular structure into a diamond pattern.
  • the tubular prosthesis structures will generally include a plurality of circumferentially spaced-apart box elements joined near the center hinge regions. By appropriately locating weakened hinge regions in particular ones of the box elements, a generally uniform pattern of opening can be provided.
  • weakened hinge region refers to the relative stiffness or pending resistance of one hinge region to another. Typically, all hinge regions will be “weak” relative to the struts. That is, as a prosthesis is expanded, the struts will resist deformation and remain essentially straight while deflecting relative to each other about the hinge regions.
  • the present invention further provides that the "weakened hinge regions,” i.e., those that are more bendable than others of the hinge regions, will deflect first so that initial expansion occurs in selected regions of the prosthesis where the weakened hinge regions are present .
  • the pattern of weakened hinge regions will usually be selected so that a plurality of circumferentially spaced- apart regions (which are preferably uniformly distributed about the periphery) are provided about the stent, which regions initially opened to provide for more uniform opening characteristics as the prosthesis is deployed.
  • the relative weakness and strength of the various hinge regions can be provided in a variety of ways. For example, it may be possible to selectively treat individual hinge regions with heat, radiation, mechanical working, or combinations thereof, so that the mechanical characteristics 7 of the hinge region are altered, i.e., so that selected hinge regions will bend or deflect with a greater or lesser expansion force than others of the hinge regions.
  • the strength of the hinge regions will be programmed by controlling the relative cross-sectional dimensions of the different hinge regions.
  • the weakened hinge regions will have cross-sectional dimensions which are selected so that the force required to "open" the hinge is less than that required for other non-weakened hinge regions.
  • the hinge will have a section in which the height in the radial direction remains constant (i.e.
  • the hinge regions will have a rectangular cross-sectional geometry where the width is the broadest dimension and is aligned circumferentially within the tubular prosthesis.
  • the width of the weakened hinge region will be reduced by from about 20% to 30% relative to the widths of the other, non- weakened hinge regions. Since bending will occur about a radial axis which is normal to the width dimension, the moment of inertia about the bending axis will be directly proportional to the third power of the width. Thus, even very small differences in width will provide a significant difference in bending strength.
  • the width of the hinge regions may be readily controlled during fabrication by adjusting the width. This will be a particularly convenient _-,
  • the hinge regions may be defined by cutting notches or voids into structural material of the hinge region.
  • V- shaped notches may be cut into the hinge region on the side which undergoes compression during opening of the hinge .
  • a C-shaped void may be cut into the same side of the hinge region.
  • the hinge region will include opposed stops which will engage each other as the hinge region is opened to a predefined angle, typically from 20° to 40°. Once the opposed stops engage each other, the hinge region will be substantially strengthened so that further opening of the hinge is inhibited.
  • the prosthesis can be programmed so that the other group (s) of hinge regions will then start or continue to open after opening of the first group of hinge regions has been inhibited by the opposed stops.
  • the prostheses described above may be delivered to a body lumen by applying a radially outward force within a lumen of the prosthesis to radially expand the prosthesis.
  • the weakened hinge regions will yield before the other hinge regions, as described above, to enhance uniformity of opening.
  • a radially expansible tubular prosthesis comprises an expansible tubular shell, wherein substantially the entire inner and/or outer surface of the shell is plated with a layer of radiopaque material.
  • the tubular prosthesis will be composed of stainless steel and the radiopaque material will be selected from the group consisting of gold, platinum, platinum/iridium, tungsten, tantalum, or the like.
  • the radiopaque material will be plated to a thickness selected to enhance fluoroscopic visibility of the entire length of the prosthesis while permitting sufficient fluoroscopic translucence so that the lumen inside the prosthesis may be inspected fluoroscopically .
  • the layer will preferably be applied in a thickness in a range from 0.01 mm to 0.03 mm.
  • the radially expansible tubular prostheses having the plated radiopaque layers as described above may be delivered while fluoroscopically viewing a target region within a body lumen.
  • prosthesis is positioned in the body lumen while observing the fluoroscopic image of the entire prosthesis.
  • the prosthesis is then deployed at the target site.
  • such prosthesis will be malleable and composed of stainless steel, but the method may also apply to superelastic, shape memory alloy, and other self-deploying prostheses.
  • FIG. 1 is a perspective view of a prior art serpentine stent.
  • Fig. 2 illustrates the serpentine stent of Fig. 1 prior to expansion in a "rolled-out" view.
  • Fig. 3 illustrates the serpentine stent of Fig. 1 after partial expansion in a "rolled-out" view.
  • Fig. 4 is a "rolled-out" view of a serpentine stent similar to that illustrated in Figs. 1-3, modified according to the principles of the present invention.
  • Fig. 5 is a "rolled-out" view of the stent of Fig. 4 after partial deployment.
  • Fig. 6 is a detailed "rolled-out" view of a portion of the stent of Figs. 4 and 5, after full deployment.
  • Figs. 7 and 7A illustrates an alternative embodiment of a stent constructed in accordance with the principles of the present invention which employs hinge regions having opposed stop surfaces .
  • Fig. 8 illustrates the stent of Fig. 7 after partial deployment .
  • Fig. 9 illustrates the stent of Figs. 7 and 8 after full deployment.
  • Figs. 10 and 10A illustrates another embodiment of a stent constructed in accordance with the principles of the present invention. __.
  • Fig. 11 illustrates the stent of Fig. 10, after partial deployment.
  • Fig. 12 illustrates yet another embodiment of a stent constructed in accordance with the principles of the present invention.
  • Fig. 13 illustrates the stent of Fig. 12 after partial deployment.
  • Fig. 14 is a graph illustrating the opening characteristics of the stent of Figs. 12 and 13.
  • Figs. 15A and 15B illustrate the opening characteristics of a hinge region having a substantially uniform width.
  • Figs 16A and 16B illustrate the opening characteristics of a hinge region having a narrowed width.
  • Figs. 17A and 17B illustrate the opening characteristics of a first embodiment of a hinge region having a pair of opposed narrowed sections.
  • Figs. 18A and 18B illustrate the opening characteristics of a second embodiment of a hinge region having a pair of opposed narrowed sections.
  • the present invention provides devices and methods for the endolumenal placement of prostheses, particularly within the vascular system for the treatment of cardiovascular disease, such as vascular stenoses, dissections, aneurysms, and the like.
  • the apparatus and methods are also useful for placement in other body lumens, such as the ureter, urethra, biliary tract, gastrointestinal tract and the like, for the treatment of other conditions which may benefit from the introduction of a reinforcing or protective structure within the body lumen.
  • endolumenally will mean placement by percutaneous or cutdown procedures, wherein the prosthesis is translumenally advanced through the body lumen from a remote location to a target site in the lumen. In vascular procedures, the prostheses will typically be introduced 11
  • a lumenal prosthesis according to the present invention will comprise at least one radially expansible, usually tubular body segment.
  • radially expansible it is meant that the body segment can be converted from a small diameter configuration (used for endolumenal placement) to a radially expanded, usually cylindrical, configuration which is achieved when the prosthesis is implanted at the desired target site.
  • the prosthesis will be non-resilient, e.g., malleable, thus requiring the application of an internal force to expand it at the target site.
  • the expansive force can be provided by a balloon catheter, such as an angioplasty balloon for vascular procedures.
  • the dimensions of the lumenal prosthesis will depend on its intended use. Typically, the prosthesis will have a length in the range from 0.5 cm to 10 cm, usually being from about 1 cm to 5 cm, for vascular applications.
  • the small (radially collapsed) diameter of cylindrical prostheses will usually be in the range from about 1 mm to 10 mm, more usually being in the range from 1.5 mm to 6 mm for vascular applications.
  • the expanded diameter will usually be in the range from about 2 mm to 30 mm, preferably being in the range from about 2.5 mm to 15 mm for vascular applications.
  • the body segments may be formed from conventional malleable materials used for body lumen stents and grafts, typically being formed from metals, such as 300 series stainless steel.
  • the body segments of the tubular prostheses will comprise a plurality of struts joined together by hinge regions.
  • the struts and hinge regions will be formed into conventional patterns of the type previously employed in stents and grafts.
  • the struts and hinge regions may be formed into serpentine patterns, including both S- shaped serpentine rings, such as those illustrated in EP 679,372, as well as Z-shaped or zig-zag stents, such as those illustrated in U.S. Patent No. 5,292,331.
  • the body segments may also comprise box elements, such as those utilized in the Pal az stent, which is presently being manufactured by Johnson and Johnson Interventional Systems, and which is generally described in U.S. Patent No. 4,776,337.
  • the present invention provides improvements over such conventional prosthesis structures by controlling the order of expansion of different circumferentially spaced-part regions of the prostheses.
  • radial expansion of any circumferential portion of the prosthesis is controlled by adjusting the strength or weakness of at least some of the hinge region (s) located in that region of the prosthesis.
  • a plurality of circumferentially spaced-apart regions of the prosthesis will have hinge regions which are weakened relative to the hinge regions in other portions of the prosthesis. By distributing these weakened hinge regions equally about the circumference of the prosthesis, the uniform pattern of expansion can be provided. Such uniformity is particularly desirable when a stent may become implanted after only partial expansion. If expansion of the stent is not uniformly distributed, as illustrated in Fig. 3 discussed above, support to a portion of the surrounding lumenal wall may be significantly compromised. The present invention ensures against such poor distribution of the supporting struts of the prosthesis after expansion.
  • the stent 20 is similar to prior art stent 10 and includes a plurality of struts 22 joined at the respective ends by hinge regions 24.
  • the stent 20, however, is modified so that ten of the hinge regions 24 are weakened relative to a pair of the hinge regions 24a.
  • the hinge regions 24a are shaded and may have an increased width or other structural modification, as discussed generally above, so that a substantially greater radial expansion force is required to open the immediately adjacent struts 22a than the non-adjacent struts 22.
  • the nature of the structural differences between the relatively weak hinge regions 22 and the relatively strong hinge regions 22a is not critical. It is necessary only that the hinge regions be modified in some way so that the adjacent struts 22 and 22a open in the desired order, i.e. with the struts 22a adjacent the stronger hinge regions 24a opening after the struts 22 adjacent the weakened hinge regions 22.
  • the stent 20 may be fabricated from any small diameter tubing comprised of a desired material, e.g. stainless steel hypotube .
  • the pattern of struts and hinges may be formed in the hypotube by conventional patterning techniques including laser cutting, sinker EDM, photolithography and the like. Suitable laser cutting techniques are described in U.S. Patent No. 5,073,694, and suitable photolithographic fabrication techniques are described in U.S. Patent No. 5,421,955, the full disclosures of which are incorporated herein by reference. Using such fabrication techniques, the relative widths of the hinge regions 24 (as well as the widths and shapes of the hinge regions in subsequent embodiments) may be precisely controlled. Referring now to Figs. 7-9, a stent 30 employing an alternative pattern of struts 32 and hinges 34 and 36 is illustrated. Stent 30 comprises a pair of serpentine body segments 31a and 31b joined by beams 38, as illustrated. The --,
  • hinge regions 36 are weakened relative to hinge regions 34 by formation of one or a pair of C-shaped cut-outs 40, as best illustrated in 57A.
  • the cut-outs 40 reduce the width of the section 42 of hinge region 36 which joins the adjacent struts 32.
  • the cut-outs 40 further define a pair of opposed stop surfaces 44 which are spaced-apart by a distance selected to permit the adjacent struts 32 to open by desired angle, typically in the range from 20° to 40°. After the stop surfaces 44 engage each other, further opening of the adjacent struts 32 will be inhibited, as illustrated in Figs. 8 and 9.
  • hinge regions 40 with opposed stop surfaces can be advantageous in several respects. First, it allows the weakened hinge regions to be quite weak during the initial expansion, but thereafter strengthened when a desired deployment configuration (i.e. strut deployment angle a as shown in Fig. 8) has been achieved. Thereafter, the hinge regions 36 may actually become strengthened relative to the other hinge regions 34. Thus, the remaining hinge regions 34 will open upon further radial internal expansion of the stent 30. In this way, a very uniform pattern of expansion of all hinge regions, both weakened and non-weakened may ultimately be achieved.
  • a desired deployment configuration i.e. strut deployment angle a as shown in Fig. 8
  • the weakened hinge regions 36 will fully deploy prior to any significant opening of any of the non-weakened hinge regions 34. After the stop surfaces 44 have been engaged, however, the remaining hinge regions 34 will then open, providing a full deployment pattern as illustrated in Fig. 9.
  • a stent 50 constructed in accordance with the principles of the present invention is illustrated in Figs. 10, 10A, and 11.
  • the stent 50 is a zigzag stent comprising struts 52 joined by hinge regions 54 and 56.
  • the hinge regions 56 are weakened relative to hinge regions 54 by provision of a generally V-shaped notch 58, as illustrated in Fig. 10A.
  • the notch 58 includes a pair of opposed stop surfaces 60 which act to prevent deflection of struts 52 beyond predetermined angular limit, as described generally above in connection with the embodiments of Figs 7- 15
  • Fig. 11 Partial deployment of the stent 50 is illustrated in Fig. 11 where a pair of evenly expanded regions 66 are uniformly arranged about a pair of non-expanded regions 68.
  • the stent 80 includes a total of six box elements or structures, each including four struts 82 joined by four hinge regions. Certain of the box structures will be joined by weakened hinge regions 84 and 88, while others of the box structures will be joined by non- weakened hinge regions 86 and 90. Circumferentially adjacent box structures are joined by tabs 94 which exert a radially expansive force on the hinge regions 88 and 90 as the stent 80 is expanded. As best seen in Fig. 13, such a construction provides for initial yielding of the three of box structures having weakened hinge regions while the remaining box structures do not significantly expand at the onset .
  • Fig. 13 is an idealized graph showing the relationship between the opening force applied to a rolled-out stent structure, as shown in Fig. 12, and the overall deflection or degree of opening.
  • a hinge region 100 joining a pair of adjacent struts 102 is illustrated.
  • the hinge region 100 is shown as having a width and cross-sectional area which is the same as that for the adjacent struts 102.
  • the hinge region 100 will yield because of the stress concentration which occurs within the hinge region.
  • the hinge region 100 may be considered either "weakened” or “non-weakened” within the definitions of the present invention depending on the nature of the other hinge region (s) within any particular stent or prosthesis structure. That is, the terms "weakened” and “non- weakened” are relative only and meant to assign the order of opening, with the weakened hinge regions opening before the non-weakened hinge regions.
  • Figs. 16A and 16B illustrate a hinge region 110 having a reduced width compared to the width of the adjacent struts 112.
  • the hinge regions 110 will be weakened hinge regions and the hinge regions 100 will be non-weakened hinge regions. It will be appreciated, however, that hinge regions 110 may be provided with different degrees of narrowing, resulting in a hierarchy of weakened and non- 17 weakened hinge regions within any particular stent structure. Opening of the hinge region 110 will occur about a central point defined by the hinge region 110.
  • FIG. 17A and 17B Another hinge region 120 is illustrated in Fig. 17A and 17B.
  • the hinge region 120 itself has a width which is generally the same as adjacent struts 122.
  • the opening characteristics of the hinge region are defined by a pair of narrowed regions 124 which are located at the transition between the U-shaped apex of the hinge and the beams of the adjacent struts 122. As the struts 122 are opened, bending will occur preferentially in the narrowed regions 124, as shown in Fig. 17B. Some opening and bending may occur within the U-shaped portion of the hinge 120, although it will generally account for only a small portion of the opening of struts 122.
  • Hinge region 130 is similar to hinge region 120, except that the width of the U-shaped portion of the hinge is increased relative to the widths of the adjacent struts 132. Thus, substantially all bending will occur in the narrow regions 134, as shown in Fig. 18B.
  • the prosthesis described above may be plated with radiopaque materials in order to adjust the radiopacity of the stent.
  • the stents will be uniformly plated over their entire lengths, either on the inside, outside, or both sides of the body segments of the stent. Such plating is particularly desirable with stainless steel and other materials which are not inherently radiopaque.
  • the radiopaque material should be bioco patible, preferably being a metal which can be electroplated onto the stent, more preferably being gold, platinum, tantalum, tungsten, or alloys thereof.
  • the material should be plated until sufficient radiopacity has been imparted so that the stents are observable under conventional fluoroscopy, but preferably permitting some fluoroscopic visibility through the stent.
  • the optimum thicknesses are in the range from 0.01 mm to 0.03 mm.

Abstract

A radially expansible lumenal prosthesis comprises one or more body segments which include struts (12) and hinge regions (40) between the struts (32). Certain of the hinge regions (36) are weakened relative to others so that the expansion characteristics of the prosthesis may be programmed. In particular, by distributing the weakened hinge regions (36) circumferentially about the body segment, uniform expansion of the prosthesis can be improved, even when the prosthesis is only partially deployed.

Description

TUBULAR PROSTHESIS HAVING IMPROVED EXPANSION AND IMAGING CHARACTERISTICS
BACKGROUND OF THE INVENTION 1. Field of the Invention
The present invention relates generally to the structure of radially expansible lumenal prostheses, including stents and grafts. More particularly, the present invention relates to the structure of prostheses having controlled expansion characteristics and controlled radiopacity.
Lumenal prostheses are provided for a variety of medical purposes. For example, lumenal stents can be placed in various body lumens, such as blood vessels, the ureter, the urethra, the biliary tract, and the gastrointestinal tract, for maintaining patency. Such stents are particularly useful for placement in pre-dilated atherosclerotic sites in blood vessels. Lumenal grafts can be placed in blood vessels to provide support in diseased regions, such as abdominal and other aneurysms .
Lumenal stents and other prostheses are available in a wide variety of configurations, including helical coils, rolled tubular sleeves, serpentine rings, zig-zag rings, expansible box constructions, and the like. Each of these configurations may also be provided as either a self -expanding prothesis, typically being formed from an alloy displaying superelastic and/or shape memory properties, such as nickel titanium, or as a malleable prosthesis which is deployed by internal expansion of a balloon to radially expand the prosthesis structure.
Of particular interest to the present invention, are serpentine, zig-zag, and box stents which comprise a plurality of strut elements joined by malleable or plastically deformable hinge regions . Such prostheses are expanded by applying a radially outward internal force within a lumen of the prosthesis, typically by expanding a balloon catheter --,
2 therein. As a result of such radially expansive forces, the hinge regions yield and the struts open away from each other to increase the diameter and peripheral dimension of the prostheses . While stents and other prostheses having such structures have been quite successful, they can suffer from non-uniform opening characteristics, as described in more detail below.
An exemplary prosthesis construction is shown in Fig. 1, where a serpentine stent 10 comprises struts 12 joined by hinge regions 14. The particular stent 12 illustrated includes a total of twelve struts 12 joined by twelve hinge regions 14, with six hinge regions being disposed at each end of the stent . Ideally, as the stent 12 is expanded by a balloon, each of the hinge regions 12 will open simultaneously at an equal rate so that the angles between adjacent struts 12 remain equal at all times during expansion. Unfortunately, even very small differences in the mechanical characteristics of the different hinge regions 12 can result in significantly different opening rates, as discussed below. Additionally, when a stent is deployed by a pre-folded balloon, certain internal surfaces of the stent may experience greater tangential forces than experienced by other surfaces, causing an uneven expansion.
Figs. 2 and 3 illustrate stent 10 in a "rolled-out" view. Fig. 2 shows the stent in its non-expanded configuration prior to deployment. Fig. 3 shows the stent in a typical configuration after partial opening as a result of internal balloon expansion. The uneven pattern of Fig. 3 will result when hinge regions 14a are mechanically stronger than hinge regions 14b, resulting in hinge regions 14b opening more readily than hinge regions 14a. A similarly uneven expansion pattern may also result from non-uniform tangential forces between the balloon and the interior surfaces of the stent, or from a combination of these forces and differences in the strengths of the hinge regions. It will be appreciated that such non-uniformity results in a very poor distribution of support about the periphery of the body lumen being treated. As illustrated in Fig. 3, approximately one-half of the 3 periphery of the body lumen would be supported by the four struts 12b, while the remaining one-half of the periphery would be supported by eight struts 12a. While the poor distribution of stent opening may be at least partially reduced as the stent 10 is further expanded, in many cases the stent 10 will only be partially opened after the deployment is complete. In such cases, the non-uniform strut distribution pattern will be a significant problem.
A separate problem in stent construction and deployment relates to the ability to detect the stent fluoroscopically during the deployment procedure. Stents composed of nickel titanium alloys and other radiopaque materials can be readily observed fluoroscopically if the cross-sections of their components are sufficiently large. If the stent is highly radiopaque, however, the stent itself, even in its expanded condition, can interfere with subsequent fluoroscopic examination of the treated area to confirm that the body lumen remains patent. In contrast, stainless steel and other common stent materials are generally radiolucent, i.e. they permit fluoroscopic examination therethrough. Such stents are advantageous since they do not prevent subsequent fluoroscopic examination of the treated region of the body lumen. They are, however, much more difficult to position accurately and usually require attachment of a separate radiopaque marker (s).
For these reasons, it would be desirable to provide improved stents and other lumenal protheses . In particular, it would be desirable to provide radially expansible stents and prostheses comprising strut and hinge regions, where the opening characteristics of the struts may be "programmed" to assure uniformity. Additionally, it would be desirable to provide improved stents and other prostheses having radiopacity characteristics which permit both tracking during deployment and subsequent visualization of the treated lumen after deployment. The present invention will provide at least some of the desired improvements. 2. Description of the Background Art
EP 662 307 describes an expansible stent having serpentine elements having regions with varying degrees of curvature to provide controlled expansion characteristics. EP 679 372 describes an expansible stent which is plated with a radiopaque material at each end to enhance fluoroscopic visibility.
Copending application serial no. 08/463,166, filed on June 5, 1996, describes a radially expansible stent which could employ the weakened hinge regions of the present invention to control deployment. The full disclosure of this application is incorporated herein by reference.
SUMMARY OF THE INVENTION The present invention provides improved radially expansible tubular prostheses and methods for their endolu enal placement within body lumens, particularly blood vessels. The prostheses may be in the form of stents, intended for maintaining lumenal patency, or may be in the form of grafts, intended for protecting or enhancing the strength of the lumenal wall . The prostheses of the present invention will be plastically deformable or malleable and radially expansible by the application of a radially outward internal force, typically applied by a balloon catheter expanded within a lumen of the prosthesis.
In a first aspect of the present invention, the radially expansible tubular prosthesis comprises at least one serpentine, zig-zag, or box element having struts joined together by hinge regions which yieldably open in response to a radially outwardly directed internal force. Selected ones of the hinge regions are weakened relative to others so that the weakened hinge regions open before the other (non-weakened or strengthened) hinge regions. Usually, it will sufficient to provide only two "groups" of hinge regions, (i.e., one group which is weakened relative to the other) but it will also be possible to provide three, four, or more different groups of hinge regions, each group programmed to open in response to successively greater expansion forces. By 5 properly distributing the weakened and non-weakened hinge regions about the tubular prosthesis, usually but not necessarily distributing the weakened regions evenly about the periphery, the stent can be "programmed" to open in a generally uniform manner. That is, opening of the stent will not be confined to a limited region in one portion or on one side of the stent.
Exemplary serpentine (or zig-zag) elements will usually comprise a plurality of struts having substantially equal lengths joined together in a reversing pattern. The reversing pattern will typically comprise repeating S- shaped hinge regions or repeating Z-shaped hinge regions. The latter pattern is commonly referred to a zig-zag stent.
Box elements will typically comprise a plurality of struts and hinge regions joined in a rectangular pattern, where the rectangle opens to a diamond or lozenge pattern as the prosthesis is expanded. Preferably, the box elements each include four struts joined by four hinges. The struts are arranged in two colinear pairs, each with one hinge region therebetween. The two pairs of struts are then joined together in parallel, with a single hinge at each end. Box elements are attached to each other at or near the hinge regions between the colinear struts, with the expansion force being applied through these hinge regions. In this way, the box elements open into the diamond or lozenge pattern as the prosthesis is radially expanded.
In further preferred aspects of the present invention, the weakened hinge regions are disposed between the ends of adjacent pairs of parallel struts. In this way, the hinge region will act as the center of deflection (or in some cases centers as described in detail below) about which the two adjacent struts open as the prosthesis is expanded. In other cases, however, the weakened hinge regions may be disposed between adjacent ends of pairs of colinear struts. In such cases, the struts will usually be initially straight
(axially aligned) and will deform about a hinge region between the struts as the prosthesis is opened. The serpentine or zig-zag structures will typically comprise a plurality of parallel, adjacent struts which are joined by hinge regions between pairs of struts on alternating sides of the prosthesis element. By peripherally disposing weakened hinge regions evenly about the tubular prosthesis (as described in much greater detail below) , a generally uniform pattern of opening of the prosthesis can be assured. Box elements will generally comprise at least four struts, with the inner ends of the struts being joined in a colinear manner and the outside ends of the struts being joined in a parallel manner. Such a hinge pattern will provide opening of the original rectangular structure into a diamond pattern. The tubular prosthesis structures will generally include a plurality of circumferentially spaced-apart box elements joined near the center hinge regions. By appropriately locating weakened hinge regions in particular ones of the box elements, a generally uniform pattern of opening can be provided.
The phrase "weakened hinge region" refers to the relative stiffness or pending resistance of one hinge region to another. Typically, all hinge regions will be "weak" relative to the struts. That is, as a prosthesis is expanded, the struts will resist deformation and remain essentially straight while deflecting relative to each other about the hinge regions. The present invention further provides that the "weakened hinge regions," i.e., those that are more bendable than others of the hinge regions, will deflect first so that initial expansion occurs in selected regions of the prosthesis where the weakened hinge regions are present . In particular, the pattern of weakened hinge regions will usually be selected so that a plurality of circumferentially spaced- apart regions (which are preferably uniformly distributed about the periphery) are provided about the stent, which regions initially opened to provide for more uniform opening characteristics as the prosthesis is deployed.
The relative weakness and strength of the various hinge regions can be provided in a variety of ways. For example, it may be possible to selectively treat individual hinge regions with heat, radiation, mechanical working, or combinations thereof, so that the mechanical characteristics 7 of the hinge region are altered, i.e., so that selected hinge regions will bend or deflect with a greater or lesser expansion force than others of the hinge regions. Preferably, however, the strength of the hinge regions will be programmed by controlling the relative cross-sectional dimensions of the different hinge regions. Usually, the weakened hinge regions will have cross-sectional dimensions which are selected so that the force required to "open" the hinge is less than that required for other non-weakened hinge regions. Usually, the hinge will have a section in which the height in the radial direction remains constant (i.e. it will be the same as the remainder of the hinge, struts, and other portions of the tubular prosthesis) while the width in the circumferential direction will be reduced by up to 30% relative to the non- weakened hinge regions. It will be appreciated, of course, that "weakened" and "non-weakened" are relative terms, and it would be possible to augment or increase the width of the non- weakened regions relative to the weakened regions. It will also be possible to provide two or more discrete narrowings within a single hinge region, or to provide one or more narrowings in the regions of the struts immediately adjacent to the hinge regions. Specific designs for such weakened hinge regions will be presented in detail below.
In a particularly preferred embodiment, the hinge regions will have a rectangular cross-sectional geometry where the width is the broadest dimension and is aligned circumferentially within the tubular prosthesis. Typically, the width of the weakened hinge region will be reduced by from about 20% to 30% relative to the widths of the other, non- weakened hinge regions. Since bending will occur about a radial axis which is normal to the width dimension, the moment of inertia about the bending axis will be directly proportional to the third power of the width. Thus, even very small differences in width will provide a significant difference in bending strength. Moveover, the width of the hinge regions may be readily controlled during fabrication by adjusting the width. This will be a particularly convenient _-,
8 method when the prosthesis is formed by laser, EDM, or photolithographic etching of a tubular material.
In a specific aspect of the present invention, the hinge regions may be defined by cutting notches or voids into structural material of the hinge region. For example, V- shaped notches may be cut into the hinge region on the side which undergoes compression during opening of the hinge . Alternatively, a C-shaped void may be cut into the same side of the hinge region. In both cases, the hinge region will include opposed stops which will engage each other as the hinge region is opened to a predefined angle, typically from 20° to 40°. Once the opposed stops engage each other, the hinge region will be substantially strengthened so that further opening of the hinge is inhibited. By properly selecting the bending strengths of the other hinge regions, the prosthesis can be programmed so that the other group (s) of hinge regions will then start or continue to open after opening of the first group of hinge regions has been inhibited by the opposed stops. In a second aspect of the present invention, the prostheses described above may be delivered to a body lumen by applying a radially outward force within a lumen of the prosthesis to radially expand the prosthesis. In particular, the weakened hinge regions will yield before the other hinge regions, as described above, to enhance uniformity of opening.
In a third aspect of the present invention, a radially expansible tubular prosthesis comprises an expansible tubular shell, wherein substantially the entire inner and/or outer surface of the shell is plated with a layer of radiopaque material. Typically, the tubular prosthesis will be composed of stainless steel and the radiopaque material will be selected from the group consisting of gold, platinum, platinum/iridium, tungsten, tantalum, or the like. Preferably, the radiopaque material will be plated to a thickness selected to enhance fluoroscopic visibility of the entire length of the prosthesis while permitting sufficient fluoroscopic translucence so that the lumen inside the prosthesis may be inspected fluoroscopically . In the case of 9 gold, the layer will preferably be applied in a thickness in a range from 0.01 mm to 0.03 mm.
In a fourth aspect of the present invention, the radially expansible tubular prostheses having the plated radiopaque layers as described above may be delivered while fluoroscopically viewing a target region within a body lumen. In prosthesis is positioned in the body lumen while observing the fluoroscopic image of the entire prosthesis. The prosthesis is then deployed at the target site. Typically, such prosthesis will be malleable and composed of stainless steel, but the method may also apply to superelastic, shape memory alloy, and other self-deploying prostheses.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a perspective view of a prior art serpentine stent.
Fig. 2 illustrates the serpentine stent of Fig. 1 prior to expansion in a "rolled-out" view.
Fig. 3 illustrates the serpentine stent of Fig. 1 after partial expansion in a "rolled-out" view.
Fig. 4 is a "rolled-out" view of a serpentine stent similar to that illustrated in Figs. 1-3, modified according to the principles of the present invention.
Fig. 5 is a "rolled-out" view of the stent of Fig. 4 after partial deployment.
Fig. 6 is a detailed "rolled-out" view of a portion of the stent of Figs. 4 and 5, after full deployment.
Figs. 7 and 7A illustrates an alternative embodiment of a stent constructed in accordance with the principles of the present invention which employs hinge regions having opposed stop surfaces .
Fig. 8 illustrates the stent of Fig. 7 after partial deployment .
Fig. 9 illustrates the stent of Figs. 7 and 8 after full deployment.
Figs. 10 and 10A illustrates another embodiment of a stent constructed in accordance with the principles of the present invention. __.
10
Fig. 11 illustrates the stent of Fig. 10, after partial deployment.
Fig. 12 illustrates yet another embodiment of a stent constructed in accordance with the principles of the present invention.
Fig. 13 illustrates the stent of Fig. 12 after partial deployment.
Fig. 14 is a graph illustrating the opening characteristics of the stent of Figs. 12 and 13. Figs. 15A and 15B illustrate the opening characteristics of a hinge region having a substantially uniform width.
Figs 16A and 16B illustrate the opening characteristics of a hinge region having a narrowed width. Figs. 17A and 17B illustrate the opening characteristics of a first embodiment of a hinge region having a pair of opposed narrowed sections.
Figs. 18A and 18B illustrate the opening characteristics of a second embodiment of a hinge region having a pair of opposed narrowed sections.
DESCRIPTION OF THE SPECIFIC EMBODIMENT
The present invention provides devices and methods for the endolumenal placement of prostheses, particularly within the vascular system for the treatment of cardiovascular disease, such as vascular stenoses, dissections, aneurysms, and the like. The apparatus and methods, however, are also useful for placement in other body lumens, such as the ureter, urethra, biliary tract, gastrointestinal tract and the like, for the treatment of other conditions which may benefit from the introduction of a reinforcing or protective structure within the body lumen.
The prostheses will be placed endolumenally. As used herein, "endolumenally" will mean placement by percutaneous or cutdown procedures, wherein the prosthesis is translumenally advanced through the body lumen from a remote location to a target site in the lumen. In vascular procedures, the prostheses will typically be introduced 11
"endovascularly" using a catheter over a guidewire under fluoroscopic guidance. The catheters and guidewires may be introduced through conventional access sites to the vascular system, such as through the femoral artery, or brachial and subclavian arteries, for access to the coronary arteries. A lumenal prosthesis according to the present invention will comprise at least one radially expansible, usually tubular body segment. By "radially expansible," it is meant that the body segment can be converted from a small diameter configuration (used for endolumenal placement) to a radially expanded, usually cylindrical, configuration which is achieved when the prosthesis is implanted at the desired target site. The prosthesis will be non-resilient, e.g., malleable, thus requiring the application of an internal force to expand it at the target site. Typically, the expansive force can be provided by a balloon catheter, such as an angioplasty balloon for vascular procedures.
The dimensions of the lumenal prosthesis will depend on its intended use. Typically, the prosthesis will have a length in the range from 0.5 cm to 10 cm, usually being from about 1 cm to 5 cm, for vascular applications. The small (radially collapsed) diameter of cylindrical prostheses will usually be in the range from about 1 mm to 10 mm, more usually being in the range from 1.5 mm to 6 mm for vascular applications. The expanded diameter will usually be in the range from about 2 mm to 30 mm, preferably being in the range from about 2.5 mm to 15 mm for vascular applications. The body segments may be formed from conventional malleable materials used for body lumen stents and grafts, typically being formed from metals, such as 300 series stainless steel.
The body segments of the tubular prostheses will comprise a plurality of struts joined together by hinge regions. Usually, the struts and hinge regions will be formed into conventional patterns of the type previously employed in stents and grafts. For example, the struts and hinge regions may be formed into serpentine patterns, including both S- shaped serpentine rings, such as those illustrated in EP 679,372, as well as Z-shaped or zig-zag stents, such as those illustrated in U.S. Patent No. 5,292,331. The body segments may also comprise box elements, such as those utilized in the Pal az stent, which is presently being manufactured by Johnson and Johnson Interventional Systems, and which is generally described in U.S. Patent No. 4,776,337.
The present invention provides improvements over such conventional prosthesis structures by controlling the order of expansion of different circumferentially spaced-part regions of the prostheses. In particular, radial expansion of any circumferential portion of the prosthesis is controlled by adjusting the strength or weakness of at least some of the hinge region (s) located in that region of the prosthesis. A plurality of circumferentially spaced-apart regions of the prosthesis will have hinge regions which are weakened relative to the hinge regions in other portions of the prosthesis. By distributing these weakened hinge regions equally about the circumference of the prosthesis, the uniform pattern of expansion can be provided. Such uniformity is particularly desirable when a stent may become implanted after only partial expansion. If expansion of the stent is not uniformly distributed, as illustrated in Fig. 3 discussed above, support to a portion of the surrounding lumenal wall may be significantly compromised. The present invention ensures against such poor distribution of the supporting struts of the prosthesis after expansion.
Referring now to Figs. 4-6, a first exemplary embodiment of a stent 20 constructed in accordance with the present invention will be described. The stent 20 is similar to prior art stent 10 and includes a plurality of struts 22 joined at the respective ends by hinge regions 24. The stent 20, however, is modified so that ten of the hinge regions 24 are weakened relative to a pair of the hinge regions 24a. The hinge regions 24a are shaded and may have an increased width or other structural modification, as discussed generally above, so that a substantially greater radial expansion force is required to open the immediately adjacent struts 22a than the non-adjacent struts 22. It must be understood that the nature of the structural differences between the relatively weak hinge regions 22 and the relatively strong hinge regions 22a is not critical. It is necessary only that the hinge regions be modified in some way so that the adjacent struts 22 and 22a open in the desired order, i.e. with the struts 22a adjacent the stronger hinge regions 24a opening after the struts 22 adjacent the weakened hinge regions 22.
As a result of the pattern of strong hinge regions 24a and weakened hinge regions 24, partial expansion of the stent 20 results in the pattern shown in Fig. 5. There, it can be seen that by providing only two hinge regions which are strengthened relative to the remaining hinge regions, four of the twelve struts 22 are inhibited from opening while an additional four of the struts are permitted to open only partially. Thus, at a point where the stent is approximately one-half open, the entire stent 20 will have a relatively uniform pattern of opening. Compare Fig. 5 with Fig. 3. As the stent 20 is further expanded, struts 24a adjacent the relatively strengthened hinge regions 24a will open, as shown in Fig. 6.
The stent 20 may be fabricated from any small diameter tubing comprised of a desired material, e.g. stainless steel hypotube . The pattern of struts and hinges may be formed in the hypotube by conventional patterning techniques including laser cutting, sinker EDM, photolithography and the like. Suitable laser cutting techniques are described in U.S. Patent No. 5,073,694, and suitable photolithographic fabrication techniques are described in U.S. Patent No. 5,421,955, the full disclosures of which are incorporated herein by reference. Using such fabrication techniques, the relative widths of the hinge regions 24 (as well as the widths and shapes of the hinge regions in subsequent embodiments) may be precisely controlled. Referring now to Figs. 7-9, a stent 30 employing an alternative pattern of struts 32 and hinges 34 and 36 is illustrated. Stent 30 comprises a pair of serpentine body segments 31a and 31b joined by beams 38, as illustrated. The --,
14 hinge regions 36 are weakened relative to hinge regions 34 by formation of one or a pair of C-shaped cut-outs 40, as best illustrated in 57A. The cut-outs 40 reduce the width of the section 42 of hinge region 36 which joins the adjacent struts 32. The cut-outs 40 further define a pair of opposed stop surfaces 44 which are spaced-apart by a distance selected to permit the adjacent struts 32 to open by desired angle, typically in the range from 20° to 40°. After the stop surfaces 44 engage each other, further opening of the adjacent struts 32 will be inhibited, as illustrated in Figs. 8 and 9.
The use of hinge regions 40 with opposed stop surfaces can be advantageous in several respects. First, it allows the weakened hinge regions to be quite weak during the initial expansion, but thereafter strengthened when a desired deployment configuration (i.e. strut deployment angle a as shown in Fig. 8) has been achieved. Thereafter, the hinge regions 36 may actually become strengthened relative to the other hinge regions 34. Thus, the remaining hinge regions 34 will open upon further radial internal expansion of the stent 30. In this way, a very uniform pattern of expansion of all hinge regions, both weakened and non-weakened may ultimately be achieved.
As illustrated in Fig. 8, the weakened hinge regions 36 will fully deploy prior to any significant opening of any of the non-weakened hinge regions 34. After the stop surfaces 44 have been engaged, however, the remaining hinge regions 34 will then open, providing a full deployment pattern as illustrated in Fig. 9.
Yet another embodiment of a stent 50 constructed in accordance with the principles of the present invention is illustrated in Figs. 10, 10A, and 11. The stent 50 is a zigzag stent comprising struts 52 joined by hinge regions 54 and 56. The hinge regions 56 are weakened relative to hinge regions 54 by provision of a generally V-shaped notch 58, as illustrated in Fig. 10A. The notch 58 includes a pair of opposed stop surfaces 60 which act to prevent deflection of struts 52 beyond predetermined angular limit, as described generally above in connection with the embodiments of Figs 7- 15
9. Partial deployment of the stent 50 is illustrated in Fig. 11 where a pair of evenly expanded regions 66 are uniformly arranged about a pair of non-expanded regions 68.
Referring now to Figs. 12 and 13, yet another stent 80 constructed in accordance with the principles of the present invention will be described. The stent 80 includes a total of six box elements or structures, each including four struts 82 joined by four hinge regions. Certain of the box structures will be joined by weakened hinge regions 84 and 88, while others of the box structures will be joined by non- weakened hinge regions 86 and 90. Circumferentially adjacent box structures are joined by tabs 94 which exert a radially expansive force on the hinge regions 88 and 90 as the stent 80 is expanded. As best seen in Fig. 13, such a construction provides for initial yielding of the three of box structures having weakened hinge regions while the remaining box structures do not significantly expand at the onset .
As shown in Fig. 13, the stent 80 is partially deployed, with the three box structures having weakened hinge regions being fully opened (i.e. opened to the extent that the opposed surfaces of the hinge regions 84 and 88 have closed) but with the other box structures remaining substantially unopened. As a radially expansive force continues to be applied to the stent 80, the remaining box structures will begin to deploy, but will require a greater radially expansive force than was required for opening the box structures having weakened hinge regions. The relationship between the opening force and the expansion of the stent 80 is illustrated in Fig. 14. Fig. 14 is an idealized graph showing the relationship between the opening force applied to a rolled-out stent structure, as shown in Fig. 12, and the overall deflection or degree of opening. In an initial phase of opening, shown as portion A of the figure, the box structures having weakened hinge regions will begin to open in an elastic manner. That is, over the initial opening or deflection, the opening will be elastic and the stent will return to its original configuration if the opening force is removed. After the opening force exceeds a certain level (shown as region B on -=,
16 the graph), expansion becomes plastic and non-reversible. The slope of the force (vs. deflection) required to yield the stent becomes smaller until the hinges 84 and 88 close, as shown in Fig. 13. At the point of closing, shown as region C on the graph, the slope of the force required to further open the stent 80 increases, as shown in region D of the graph. Such a greater force gradient is required to open the non- weakened box structures of the stent 80. It will be appreciated that the opening characteristics shown in Fig. 14 are idealized. For a real stent, slight differences in the opening characteristics of all of the hinge region 84, 86, 88, and 90, might result in a number of different stages showing as multiple near linear regions within the graph of Fig. 14. Referring now to Figs. 15A-18B, a variety of hinge regions which may be employed in the stents and prostheses of the present invention will be described. In Figs. 15A and 15B, a hinge region 100 joining a pair of adjacent struts 102 is illustrated. The hinge region 100 is shown as having a width and cross-sectional area which is the same as that for the adjacent struts 102. As an opening force is applied to the struts, the hinge region 100 will yield because of the stress concentration which occurs within the hinge region. It will be appreciated that the hinge region 100 may be considered either "weakened" or "non-weakened" within the definitions of the present invention depending on the nature of the other hinge region (s) within any particular stent or prosthesis structure. That is, the terms "weakened" and "non- weakened" are relative only and meant to assign the order of opening, with the weakened hinge regions opening before the non-weakened hinge regions.
Figs. 16A and 16B illustrate a hinge region 110 having a reduced width compared to the width of the adjacent struts 112. In an exemplary stent construction according to the present invention, the hinge regions 110 will be weakened hinge regions and the hinge regions 100 will be non-weakened hinge regions. It will be appreciated, however, that hinge regions 110 may be provided with different degrees of narrowing, resulting in a hierarchy of weakened and non- 17 weakened hinge regions within any particular stent structure. Opening of the hinge region 110 will occur about a central point defined by the hinge region 110.
Another hinge region 120 is illustrated in Fig. 17A and 17B. The hinge region 120 itself has a width which is generally the same as adjacent struts 122. The opening characteristics of the hinge region are defined by a pair of narrowed regions 124 which are located at the transition between the U-shaped apex of the hinge and the beams of the adjacent struts 122. As the struts 122 are opened, bending will occur preferentially in the narrowed regions 124, as shown in Fig. 17B. Some opening and bending may occur within the U-shaped portion of the hinge 120, although it will generally account for only a small portion of the opening of struts 122.
Yet another hinge region 130 is illustrated in Figs. 18A and 18B. Hinge region 130 is similar to hinge region 120, except that the width of the U-shaped portion of the hinge is increased relative to the widths of the adjacent struts 132. Thus, substantially all bending will occur in the narrow regions 134, as shown in Fig. 18B.
In another aspect of the present invention, the prosthesis described above may be plated with radiopaque materials in order to adjust the radiopacity of the stent. The stents will be uniformly plated over their entire lengths, either on the inside, outside, or both sides of the body segments of the stent. Such plating is particularly desirable with stainless steel and other materials which are not inherently radiopaque. The radiopaque material should be bioco patible, preferably being a metal which can be electroplated onto the stent, more preferably being gold, platinum, tantalum, tungsten, or alloys thereof. The material should be plated until sufficient radiopacity has been imparted so that the stents are observable under conventional fluoroscopy, but preferably permitting some fluoroscopic visibility through the stent. For gold, the optimum thicknesses are in the range from 0.01 mm to 0.03 mm. Although the foregoing invention has been described in some detail by way of illustration and example, for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims .

Claims

19WHAT IS CLAIMED IS:
1. A radially expansible tubular prosthesis comprising at least one serpentine element or box element having struts joined together by hinge regions which yieldably open in response to a radially outwardly directed internal force, wherein selected ones of the hinge regions are weakened relative to others so that said selected ones will begin to open before said others begin to open.
2. A prosthesis as in claim 1 wherein tubular prosthesis comprises a serpentine element and, the struts have substantially equal lengths and are arranged in a reversing pattern.
3. A prosthesis as in claim 2, wherein the reversing pattern is a repeating S-shaped pattern.
4. A prosthesis as in claim 2, wherein the reversing pattern is a repeating Z-shaped pattern.
5. A prosthesis as in claim 1, comprising box elements wherein each box element includes four struts joined by four hinges .
6. A prosthesis as in claim 5, wherein prior to expansion the struts are disposed in two colinear pairs with two hinge regions between each of the colinear struts and two hinges between the ends of each pair and subsequent to expansion the box transforms to a diamond pattern.
7. A prosthesis as in claim 1, wherein at least some of the weakened hinge regions are located between adjacent ends of a pair of struts.
8. A prosthesis as in claim 1, wherein at least some of the weakened hinge regions comprise pairs of narrowed sections adjacent pair of struts. __.
20 9. A prosthesis as in claim 1, wherein said selected ones of the hinge regions have a width that is reduced relative to the widths of said others of the hinge regions .
10. A prosthesis as in claim 9, wherein the widths of the selected ones of the hinge regions are reduced by from 20% to 30% relative to the widths of the others of the hinge regions .
11. A prosthesis as in claim 1, wherein at least some of the hinge regions include opposed stops which engage each other as the hinge is opened and which inhibit further opening after they engage each other.
12. A prosthesis as in claim 11, wherein the hinge regions have a C-shaped pattern.
13. A prosthesis as in claim 11, wherein the hinge regions have a generally V-shaped pattern.
14. A prosthesis as in claim 1, wherein the serpentine element extends about the full circumference of the tubular prosthesis and wherein the weakened hinge regions are distributed in a pattern that results in a plurality of equally circumferentially spaced-apart segments opening prior to segments therebetween.
15. A method for delivering a radially expansible tubular prosthesis to a body lumen, said method comprising: providing a prosthesis as in claim 1; and applying a radially outward force within a lumen of the prosthesis to radially expand said prosthesis, wherein said weakened hinge regions yield before other hinge regions.
21 16. A radially expansible tubular prosthesis comprising an expansible tubular shell wherein substantially the entire inner and/or outer surface of the shell is plated with a layer of radiopaque material .
17. A prosthesis as in claim 16, wherein the tubular prosthesis is composed of stainless steel and the radiopaque material is selected from the group consisting of gold, platinum, platinum/iridium, tungsten, and tantalum.
18. A prosthesis as in claim 16, wherein the radiopaque material is plated to a thickness selected to enhance fluoroscopic visibility of the entire length of the prosthesis while permitting some fluoroscopic viewing through the prosthesis following expansion.
19. A prosthesis as in claim 18, wherein the radiopaque material is gold plated to a thickness in the range from 0.01 mm to 0.03 mm.
20. A method for delivering a radially expansible tubular prosthesis to a body lumen, said method comprising: providing a prosthesis as in claim 17; fluoroscopically viewing a target region within the body lumen ; positioning the prosthesis in the body lumen while observing the fluoroscopic image of the entire prosthesis; and deploying the prosthesis at a site within the target region.
PCT/US1997/012833 1996-08-02 1997-07-31 Tubular prosthesis having improved expansion and imaging characteristics WO1998005270A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP10507944A JP2000516486A (en) 1996-08-02 1997-07-31 Tubular prosthesis with excellent magnifying and imaging properties
AU38089/97A AU3808997A (en) 1996-08-02 1997-07-31 Tubular prosthesis having improved expansion and imaging characteristics

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/691,661 US5922020A (en) 1996-08-02 1996-08-02 Tubular prosthesis having improved expansion and imaging characteristics
US08/691,661 1996-08-02

Publications (1)

Publication Number Publication Date
WO1998005270A1 true WO1998005270A1 (en) 1998-02-12

Family

ID=24777444

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/012833 WO1998005270A1 (en) 1996-08-02 1997-07-31 Tubular prosthesis having improved expansion and imaging characteristics

Country Status (4)

Country Link
US (1) US5922020A (en)
JP (1) JP2000516486A (en)
AU (1) AU3808997A (en)
WO (1) WO1998005270A1 (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049811A1 (en) * 1998-04-01 1999-10-07 Quanam Medical Corporation Expandable unit cell and intraluminal stent
US6071308A (en) * 1997-10-01 2000-06-06 Boston Scientific Corporation Flexible metal wire stent
JP2002532136A (en) * 1998-12-18 2002-10-02 クック インコーポレイティド Cannula tent
JP2003500101A (en) * 1999-05-20 2003-01-07 コナー メドシステムズ, インコーポレイテッド Expandable medical device with ductile hinge
JP2003515386A (en) * 1999-12-03 2003-05-07 テラメッド・インコーポレイテッド Endovascular graft system
WO2006029619A1 (en) * 2004-09-17 2006-03-23 Optiray Medizintechnik Gmbh Supporting prosthesis
US7160321B2 (en) 1998-03-30 2007-01-09 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US7279004B2 (en) 1998-03-30 2007-10-09 Innovational Holdings, Llc. Expandable medical device with curved hinge
US7479127B2 (en) 1999-05-20 2009-01-20 Innovational Holding, Llc Expandable medical device delivery system and method
EP2040643A2 (en) * 2006-07-13 2009-04-01 Icon Medical Corp. Stent
US7842083B2 (en) 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
US7850727B2 (en) 2001-08-20 2010-12-14 Innovational Holdings, Llc Expandable medical device for delivery of beneficial agent
US8257427B2 (en) 2001-09-11 2012-09-04 J.W. Medical Systems, Ltd. Expandable stent
US9034245B2 (en) 2010-03-04 2015-05-19 Icon Medical Corp. Method for forming a tubular medical device
US9107899B2 (en) 2005-03-03 2015-08-18 Icon Medical Corporation Metal alloys for medical devices
US9855159B2 (en) 2011-03-29 2018-01-02 Terumo Kabushiki Kaisha Stent and stent delivery system
US11766506B2 (en) 2016-03-04 2023-09-26 Mirus Llc Stent device for spinal fusion
US11779685B2 (en) 2014-06-24 2023-10-10 Mirus Llc Metal alloys for medical devices

Families Citing this family (226)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG85682A1 (en) * 1993-03-11 2002-01-15 Medinol Ltd Stent
EP1477133B9 (en) * 1996-03-05 2007-11-21 Evysio Medical Devices Ulc Expandable stent
US6235053B1 (en) 1998-02-02 2001-05-22 G. David Jang Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors
US20040106985A1 (en) 1996-04-26 2004-06-03 Jang G. David Intravascular stent
JP4636634B2 (en) * 1996-04-26 2011-02-23 ボストン サイエンティフィック サイムド,インコーポレイテッド Intravascular stent
US6783543B2 (en) * 2000-06-05 2004-08-31 Scimed Life Systems, Inc. Intravascular stent with increasing coating retaining capacity
RU2108070C1 (en) * 1996-07-09 1998-04-10 Борис Петрович Кручинин Microsurgical fastening device and manipulation pusher for its mounting
US7341598B2 (en) * 1999-01-13 2008-03-11 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US6835203B1 (en) 1996-11-04 2004-12-28 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6692483B2 (en) 1996-11-04 2004-02-17 Advanced Stent Technologies, Inc. Catheter with attached flexible side sheath
EP0944366B1 (en) 1996-11-04 2006-09-13 Advanced Stent Technologies, Inc. Extendible double stent
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US8211167B2 (en) 1999-12-06 2012-07-03 Boston Scientific Scimed, Inc. Method of using a catheter with attached flexible side sheath
US7591846B2 (en) * 1996-11-04 2009-09-22 Boston Scientific Scimed, Inc. Methods for deploying stents in bifurcations
US6599316B2 (en) 1996-11-04 2003-07-29 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6682536B2 (en) 2000-03-22 2004-01-27 Advanced Stent Technologies, Inc. Guidewire introducer sheath
US6315791B1 (en) 1996-12-03 2001-11-13 Atrium Medical Corporation Self-expanding prothesis
US5868782A (en) * 1996-12-24 1999-02-09 Global Therapeutics, Inc. Radially expandable axially non-contracting surgical stent
US8353948B2 (en) * 1997-01-24 2013-01-15 Celonova Stent, Inc. Fracture-resistant helical stent incorporating bistable cells and methods of use
IL131063A (en) * 1997-01-24 2005-07-25 Kentucky Oil N V Bistable spring construction for a stent and other medical apparatus
US6726829B2 (en) 1997-04-08 2004-04-27 Scimed Life Systems, Inc. Method of manufacturing a stent
US5902475A (en) * 1997-04-08 1999-05-11 Interventional Technologies, Inc. Method for manufacturing a stent
AU7420998A (en) * 1997-05-14 1998-12-08 Novo Rps Ulc Expandable stent and method for production of same
CA2241558A1 (en) 1997-06-24 1998-12-24 Advanced Cardiovascular Systems, Inc. Stent with reinforced struts and bimodal deployment
ES2290995T3 (en) * 1997-09-24 2008-02-16 Med Institute, Inc. RADIALLY EXPANDABLE ENDOPROTESIS.
US6330884B1 (en) * 1997-11-14 2001-12-18 Transvascular, Inc. Deformable scaffolding multicellular stent
US7179289B2 (en) * 1998-03-30 2007-02-20 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US20040254635A1 (en) 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
WO1999062431A1 (en) * 1998-06-02 1999-12-09 Cook Incorporated Multiple-sided intraluminal medical device
US6066169A (en) * 1998-06-02 2000-05-23 Ave Connaught Expandable stent having articulated connecting rods
US6461380B1 (en) 1998-07-28 2002-10-08 Advanced Cardiovascular Systems, Inc. Stent configuration
US6475234B1 (en) * 1998-10-26 2002-11-05 Medinol, Ltd. Balloon expandable covered stents
US8382821B2 (en) 1998-12-03 2013-02-26 Medinol Ltd. Helical hybrid stent
US20050033399A1 (en) * 1998-12-03 2005-02-10 Jacob Richter Hybrid stent
US7655030B2 (en) 2003-07-18 2010-02-02 Boston Scientific Scimed, Inc. Catheter balloon systems and methods
US6620192B1 (en) * 1999-03-16 2003-09-16 Advanced Cardiovascular Systems, Inc. Multilayer stent
US6551351B2 (en) * 1999-07-02 2003-04-22 Scimed Life Systems Spiral wound stent
US6544279B1 (en) * 2000-08-09 2003-04-08 Incept, Llc Vascular device for emboli, thrombus and foreign body removal and methods of use
US6540774B1 (en) * 1999-08-31 2003-04-01 Advanced Cardiovascular Systems, Inc. Stent design with end rings having enhanced strength and radiopacity
US6689156B1 (en) 1999-09-23 2004-02-10 Advanced Stent Technologies, Inc. Stent range transducers and methods of use
DE19951475A1 (en) * 1999-10-26 2001-05-10 Biotronik Mess & Therapieg Stent
US6679910B1 (en) * 1999-11-12 2004-01-20 Latin American Devices Llc Intraluminal stent
US6911032B2 (en) * 1999-11-18 2005-06-28 Scimed Life Systems, Inc. Apparatus and method for compressing body tissue
US6428548B1 (en) * 1999-11-18 2002-08-06 Russell F. Durgin Apparatus and method for compressing body tissue
US6537310B1 (en) * 1999-11-19 2003-03-25 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal implantable devices and method of making same
DE60127530T2 (en) * 2000-02-03 2007-12-13 Cook Inc., Bloomington IMPLANTABLE VASCULAR DEVICE
US6423090B1 (en) 2000-02-11 2002-07-23 Advanced Cardiovascular Systems, Inc. Stent pattern with staged expansion
US6616689B1 (en) 2000-05-03 2003-09-09 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6602282B1 (en) 2000-05-04 2003-08-05 Avantec Vascular Corporation Flexible stent structure
AU6539101A (en) * 2000-06-05 2001-12-17 G David Jang Intravascular stent with increasing coating retaining capacity
US6652579B1 (en) 2000-06-22 2003-11-25 Advanced Cardiovascular Systems, Inc. Radiopaque stent
US6805704B1 (en) 2000-06-26 2004-10-19 C. R. Bard, Inc. Intraluminal stents
US6440162B1 (en) 2000-07-26 2002-08-27 Advanced Cardiovascular Systems, Inc. Stent having increased scaffolding expandable bar arms
US6799637B2 (en) 2000-10-20 2004-10-05 Schlumberger Technology Corporation Expandable tubing and method
GB0020491D0 (en) 2000-08-18 2000-10-11 Angiomed Ag Stent with attached element and method of making such a stent
US7766956B2 (en) 2000-09-22 2010-08-03 Boston Scientific Scimed, Inc. Intravascular stent and assembly
US6764507B2 (en) * 2000-10-16 2004-07-20 Conor Medsystems, Inc. Expandable medical device with improved spatial distribution
US6663664B1 (en) 2000-10-26 2003-12-16 Advanced Cardiovascular Systems, Inc. Self-expanding stent with time variable radial force
US6929660B1 (en) 2000-12-22 2005-08-16 Advanced Cardiovascular Systems, Inc. Intravascular stent
NO335594B1 (en) 2001-01-16 2015-01-12 Halliburton Energy Serv Inc Expandable devices and methods thereof
US20040073294A1 (en) 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US6964680B2 (en) * 2001-02-05 2005-11-15 Conor Medsystems, Inc. Expandable medical device with tapered hinge
US6955686B2 (en) 2001-03-01 2005-10-18 Cordis Corporation Flexible stent
US6679911B2 (en) 2001-03-01 2004-01-20 Cordis Corporation Flexible stent
US6998060B2 (en) * 2001-03-01 2006-02-14 Cordis Corporation Flexible stent and method of manufacture
US6790227B2 (en) * 2001-03-01 2004-09-14 Cordis Corporation Flexible stent
AU784552B2 (en) * 2001-03-02 2006-05-04 Cardinal Health 529, Llc Flexible stent
DE10118944B4 (en) 2001-04-18 2013-01-31 Merit Medical Systems, Inc. Removable, essentially cylindrical implants
US8617231B2 (en) 2001-05-18 2013-12-31 Boston Scientific Scimed, Inc. Dual guidewire exchange catheter system
US6939373B2 (en) * 2003-08-20 2005-09-06 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6629994B2 (en) * 2001-06-11 2003-10-07 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6772479B2 (en) * 2001-06-21 2004-08-10 The Aerospace Corporation Conductive shape memory metal deployment latch hinge
US6635083B1 (en) 2001-06-25 2003-10-21 Advanced Cardiovascular Systems, Inc. Stent with non-linear links and method of use
US6749629B1 (en) 2001-06-27 2004-06-15 Advanced Cardiovascular Systems, Inc. Stent pattern with figure-eights
DE60236093D1 (en) 2001-07-26 2010-06-02 Merit Medical Systems Inc REMOVABLE STENT
US7014654B2 (en) * 2001-11-30 2006-03-21 Scimed Life Systems, Inc. Stent designed for the delivery of therapeutic substance or other agents
US7294146B2 (en) 2001-12-03 2007-11-13 Xtent, Inc. Apparatus and methods for delivery of variable length stents
US7351255B2 (en) * 2001-12-03 2008-04-01 Xtent, Inc. Stent delivery apparatus and method
US7147656B2 (en) 2001-12-03 2006-12-12 Xtent, Inc. Apparatus and methods for delivery of braided prostheses
US7309350B2 (en) 2001-12-03 2007-12-18 Xtent, Inc. Apparatus and methods for deployment of vascular prostheses
US7137993B2 (en) 2001-12-03 2006-11-21 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US8080048B2 (en) 2001-12-03 2011-12-20 Xtent, Inc. Stent delivery for bifurcated vessels
US7892273B2 (en) 2001-12-03 2011-02-22 Xtent, Inc. Custom length stent apparatus
US7270668B2 (en) * 2001-12-03 2007-09-18 Xtent, Inc. Apparatus and methods for delivering coiled prostheses
US20030135266A1 (en) 2001-12-03 2003-07-17 Xtent, Inc. Apparatus and methods for delivery of multiple distributed stents
US7182779B2 (en) 2001-12-03 2007-02-27 Xtent, Inc. Apparatus and methods for positioning prostheses for deployment from a catheter
US20040186551A1 (en) 2003-01-17 2004-09-23 Xtent, Inc. Multiple independent nested stent structures and methods for their preparation and deployment
US6911040B2 (en) * 2002-01-24 2005-06-28 Cordis Corporation Covered segmented stent
US20030204248A1 (en) * 2002-03-25 2003-10-30 Murphy Kieran P. Device viewable under an imaging beam
US7927368B2 (en) * 2002-03-25 2011-04-19 Kieran Murphy Llc Device viewable under an imaging beam
US9375203B2 (en) 2002-03-25 2016-06-28 Kieran Murphy Llc Biopsy needle
US20030181810A1 (en) 2002-03-25 2003-09-25 Murphy Kieran P. Kit for image guided surgical procedures
US7691461B1 (en) 2002-04-01 2010-04-06 Advanced Cardiovascular Systems, Inc. Hybrid stent and method of making
EP1507494A2 (en) * 2002-05-06 2005-02-23 Abbott Laboratories Endoprosthesis for controlled contraction and expansion
EP2529707B1 (en) * 2002-05-08 2015-04-15 Abbott Laboratories Endoprosthesis having foot extensions
US6656220B1 (en) 2002-06-17 2003-12-02 Advanced Cardiovascular Systems, Inc. Intravascular stent
DE10243136A1 (en) * 2002-09-17 2004-05-19 Campus Medizin & Technik Gmbh Stent for implantation in or around a hollow organ
US20040127976A1 (en) * 2002-09-20 2004-07-01 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US7331986B2 (en) * 2002-10-09 2008-02-19 Boston Scientific Scimed, Inc. Intraluminal medical device having improved visibility
US20040093056A1 (en) 2002-10-26 2004-05-13 Johnson Lianw M. Medical appliance delivery apparatus and method of use
US7875068B2 (en) 2002-11-05 2011-01-25 Merit Medical Systems, Inc. Removable biliary stent
US7959671B2 (en) 2002-11-05 2011-06-14 Merit Medical Systems, Inc. Differential covering and coating methods
US7637942B2 (en) 2002-11-05 2009-12-29 Merit Medical Systems, Inc. Coated stent with geometry determinated functionality and method of making the same
US7527644B2 (en) 2002-11-05 2009-05-05 Alveolus Inc. Stent with geometry determinated functionality and method of making the same
DE10253633B4 (en) * 2002-11-13 2011-08-11 BIOTRONIK GmbH & Co. KG, 12359 supporting structure
CA2506655A1 (en) * 2002-11-15 2004-06-03 Synecor, Llc Polymeric endoprosthesis and method of manufacture
US20040102831A1 (en) * 2002-11-22 2004-05-27 Murray Robert J. Stent having tapered edges
US7172624B2 (en) * 2003-02-06 2007-02-06 Boston Scientific Scimed, Inc. Medical device with magnetic resonance visibility enhancing structure
EP1610823B1 (en) 2003-03-28 2011-09-28 Innovational Holdings, LLC Implantable medical device with continuous agent concentration gradient
US7637934B2 (en) 2003-03-31 2009-12-29 Merit Medical Systems, Inc. Medical appliance optical delivery and deployment apparatus and method
US7604660B2 (en) 2003-05-01 2009-10-20 Merit Medical Systems, Inc. Bifurcated medical appliance delivery apparatus and method
US7625398B2 (en) * 2003-05-06 2009-12-01 Abbott Laboratories Endoprosthesis having foot extensions
US7625401B2 (en) * 2003-05-06 2009-12-01 Abbott Laboratories Endoprosthesis having foot extensions
DE10323628A1 (en) * 2003-05-20 2004-12-30 Biotronik Ag Stents made of a material with low elongation at break
US7241308B2 (en) 2003-06-09 2007-07-10 Xtent, Inc. Stent deployment systems and methods
US6916336B2 (en) * 2003-06-09 2005-07-12 Avantec Vascular Corporation Vascular prosthesis
US9039755B2 (en) 2003-06-27 2015-05-26 Medinol Ltd. Helical hybrid stent
US9155639B2 (en) 2009-04-22 2015-10-13 Medinol Ltd. Helical hybrid stent
US6840569B1 (en) * 2003-07-22 2005-01-11 Arthur Donald Leigh Caravan
US8298280B2 (en) 2003-08-21 2012-10-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7785653B2 (en) 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
US20050065437A1 (en) * 2003-09-24 2005-03-24 Scimed Life Systems, Inc. Medical device with markers for magnetic resonance visibility
US7553324B2 (en) 2003-10-14 2009-06-30 Xtent, Inc. Fixed stent delivery devices and methods
US7344557B2 (en) 2003-11-12 2008-03-18 Advanced Stent Technologies, Inc. Catheter balloon systems and methods
US7326236B2 (en) 2003-12-23 2008-02-05 Xtent, Inc. Devices and methods for controlling and indicating the length of an interventional element
US20050159810A1 (en) * 2004-01-15 2005-07-21 Farzan Filsoufi Devices and methods for repairing cardiac valves
JP4620109B2 (en) * 2004-03-23 2011-01-26 イソフラックス・インコーポレイテッド Radiopaque coatings for biomedical devices
US7323006B2 (en) 2004-03-30 2008-01-29 Xtent, Inc. Rapid exchange interventional devices and methods
US7763064B2 (en) * 2004-06-08 2010-07-27 Medinol, Ltd. Stent having struts with reverse direction curvature
EP1753369B1 (en) 2004-06-08 2013-05-29 Advanced Stent Technologies, Inc. Stent with protruding branch portion for bifurcated vessels
US8317859B2 (en) 2004-06-28 2012-11-27 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
US20050288766A1 (en) 2004-06-28 2005-12-29 Xtent, Inc. Devices and methods for controlling expandable prostheses during deployment
US7763066B2 (en) * 2004-07-28 2010-07-27 Cook Incorporated Stent with an end member having a lateral extension
US7240516B2 (en) * 2004-08-03 2007-07-10 Medtronic Vascular, Inc. Flexible resheathable stent design
WO2006036319A2 (en) * 2004-09-15 2006-04-06 Conor Medsystems, Inc. Bifurcation stent with crushable end and method for delivery of a stent to a bifurcation
US7887579B2 (en) 2004-09-29 2011-02-15 Merit Medical Systems, Inc. Active stent
CA2598164C (en) * 2004-12-08 2013-10-08 Innovational Holdings Llc Expandable medical device with differential hinge performance
US7540995B2 (en) 2005-03-03 2009-06-02 Icon Medical Corp. Process for forming an improved metal alloy stent
US8435280B2 (en) * 2005-03-31 2013-05-07 Boston Scientific Scimed, Inc. Flexible stent with variable width elements
US7402168B2 (en) 2005-04-11 2008-07-22 Xtent, Inc. Custom-length stent delivery system with independently operable expansion elements
US8628565B2 (en) * 2005-04-13 2014-01-14 Abbott Cardiovascular Systems Inc. Intravascular stent
US7731654B2 (en) 2005-05-13 2010-06-08 Merit Medical Systems, Inc. Delivery device with viewing window and associated method
US20060271170A1 (en) * 2005-05-31 2006-11-30 Gale David C Stent with flexible sections in high strain regions
EP2364676B1 (en) 2005-06-30 2018-12-19 Abbott Laboratories Endoprosthesis having foot extensions
KR100778020B1 (en) * 2005-10-24 2007-11-28 사회복지법인 삼성생명공익재단 Vascular stent which is specially designed for the multiple drug loading and better drug elution
US7540881B2 (en) * 2005-12-22 2009-06-02 Boston Scientific Scimed, Inc. Bifurcation stent pattern
US8821561B2 (en) 2006-02-22 2014-09-02 Boston Scientific Scimed, Inc. Marker arrangement for bifurcation catheter
US8298278B2 (en) * 2006-03-07 2012-10-30 Boston Scientific Scimed, Inc. Bifurcated stent with improvement securement
CA2646885A1 (en) 2006-03-20 2007-09-27 Xtent, Inc. Apparatus and methods for deployment of linked prosthetic segments
GB0609841D0 (en) * 2006-05-17 2006-06-28 Angiomed Ag Bend-capable tubular prosthesis
GB0609911D0 (en) * 2006-05-18 2006-06-28 Angiomed Ag Bend-capable stent prosthesis
US10004584B2 (en) 2006-07-10 2018-06-26 First Quality Hygienic, Inc. Resilient intravaginal device
US8613698B2 (en) 2006-07-10 2013-12-24 Mcneil-Ppc, Inc. Resilient device
US10219884B2 (en) 2006-07-10 2019-03-05 First Quality Hygienic, Inc. Resilient device
US8047980B2 (en) 2006-07-10 2011-11-01 Mcneil-Ppc, Inc. Method of treating urinary incontinence
AU2007272601B2 (en) 2006-07-10 2014-01-16 First Quality Hygienic, Inc. Resilient device
GB0616999D0 (en) * 2006-08-29 2006-10-04 Angiomed Ag Annular mesh
WO2008028964A2 (en) * 2006-09-07 2008-03-13 Angiomed Gmbh & Co. Medizintechnik Kg Helical implant having different ends
US8414637B2 (en) 2006-09-08 2013-04-09 Boston Scientific Scimed, Inc. Stent
US8778009B2 (en) * 2006-10-06 2014-07-15 Abbott Cardiovascular Systems Inc. Intravascular stent
US7951191B2 (en) * 2006-10-10 2011-05-31 Boston Scientific Scimed, Inc. Bifurcated stent with entire circumferential petal
US8545545B2 (en) 2006-10-18 2013-10-01 Innovational Holdings Llc Stent with flexible hinges
GB0622465D0 (en) * 2006-11-10 2006-12-20 Angiomed Ag Stent
US7842082B2 (en) 2006-11-16 2010-11-30 Boston Scientific Scimed, Inc. Bifurcated stent
US9622888B2 (en) * 2006-11-16 2017-04-18 W. L. Gore & Associates, Inc. Stent having flexibly connected adjacent stent elements
GB0624419D0 (en) * 2006-12-06 2007-01-17 Angiomed Ag Stenting ring with marker
US20080177373A1 (en) * 2007-01-19 2008-07-24 Elixir Medical Corporation Endoprosthesis structures having supporting features
US20080199510A1 (en) 2007-02-20 2008-08-21 Xtent, Inc. Thermo-mechanically controlled implants and methods of use
US8512392B2 (en) * 2007-03-09 2013-08-20 Boston Scientific Scimed, Inc. Stent design with struts of various angles and stiffness
US8486132B2 (en) 2007-03-22 2013-07-16 J.W. Medical Systems Ltd. Devices and methods for controlling expandable prostheses during deployment
GB0706499D0 (en) 2007-04-03 2007-05-09 Angiomed Ag Bendable stent
US7810223B2 (en) * 2007-05-16 2010-10-12 Boston Scientific Scimed, Inc. Method of attaching radiopaque markers to intraluminal medical devices, and devices formed using the same
US8211162B2 (en) * 2007-05-25 2012-07-03 Boston Scientific Scimed, Inc. Connector node for durable stent
US20090005853A1 (en) * 2007-06-26 2009-01-01 Karim Osman Integration Of Markers Into Bar Arms
US8486134B2 (en) 2007-08-01 2013-07-16 Boston Scientific Scimed, Inc. Bifurcation treatment system and methods
GB0717481D0 (en) 2007-09-07 2007-10-17 Angiomed Ag Self-expansible stent with radiopaque markers
US7959669B2 (en) * 2007-09-12 2011-06-14 Boston Scientific Scimed, Inc. Bifurcated stent with open ended side branch support
US20090076591A1 (en) * 2007-09-19 2009-03-19 Boston Scientific Scimed, Inc. Stent Design Allowing Extended Release of Drug and/or Enhanced Adhesion of Polymer to OD Surface
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
AU2008308474B2 (en) 2007-10-04 2014-07-24 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US8936567B2 (en) 2007-11-14 2015-01-20 Boston Scientific Scimed, Inc. Balloon bifurcated lumen treatment
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US7833266B2 (en) 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
US7972373B2 (en) * 2007-12-19 2011-07-05 Advanced Technologies And Regenerative Medicine, Llc Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US8277501B2 (en) * 2007-12-21 2012-10-02 Boston Scientific Scimed, Inc. Bi-stable bifurcated stent petal geometry
US9370437B2 (en) * 2007-12-26 2016-06-21 Cook Medical Technologies Llc Stent having less invasive ends
US8747456B2 (en) 2007-12-31 2014-06-10 Boston Scientific Scimed, Inc. Bifurcation stent delivery system and methods
US8926688B2 (en) 2008-01-11 2015-01-06 W. L. Gore & Assoc. Inc. Stent having adjacent elements connected by flexible webs
WO2009103977A1 (en) * 2008-02-22 2009-08-27 Athera Biotechnologies Ab Compounds and methods for the prevention or treatment of restenosis
US9101503B2 (en) 2008-03-06 2015-08-11 J.W. Medical Systems Ltd. Apparatus having variable strut length and methods of use
US20090240318A1 (en) * 2008-03-19 2009-09-24 Boston Scientific Scimed, Inc. Stent expansion column, strut and connector slit design
US8932340B2 (en) * 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US8377108B2 (en) 2008-06-02 2013-02-19 Boston Scientific Scimed, Inc. Staggered two balloon bifurcation catheter assembly and methods
EP2300093B1 (en) 2008-06-05 2016-04-20 Boston Scientific Scimed, Inc. Deflatable bifurcated device
US8821562B2 (en) 2008-09-25 2014-09-02 Advanced Bifurcation Systems, Inc. Partially crimped stent
US8828071B2 (en) 2008-09-25 2014-09-09 Advanced Bifurcation Systems, Inc. Methods and systems for ostial stenting of a bifurcation
US11298252B2 (en) 2008-09-25 2022-04-12 Advanced Bifurcation Systems Inc. Stent alignment during treatment of a bifurcation
EP2344068B1 (en) 2008-09-25 2022-10-19 Advanced Bifurcation Systems Inc. Partially crimped stent
CN101732114B (en) * 2008-11-04 2014-07-30 上海微创医疗器械(集团)有限公司 Coronary artery stent with medicine carrying grooves
US8298279B2 (en) * 2009-09-24 2012-10-30 Medtronic Vascular, Inc. Stent including a toggle lock strut
EP2549952A4 (en) 2010-03-24 2017-01-04 Advanced Bifurcation Systems, Inc. System and methods for treating a bifurcation
CA2794064A1 (en) 2010-03-24 2011-09-29 Advanced Bifurcation Systems, Inc. Methods and systems for treating a bifurcation with provisional side branch stenting
CA2794078A1 (en) 2010-03-24 2011-09-29 Advanced Bifurcation Systems, Inc. Stent alignment during treatment of a bifurcation
JP5661334B2 (en) * 2010-05-26 2015-01-28 テルモ株式会社 Stent
EP2658484A1 (en) 2010-12-30 2013-11-06 Boston Scientific Scimed, Inc. Multi stage opening stent designs
CA2826760A1 (en) 2011-02-08 2012-08-16 Advanced Bifurcation Systems, Inc. Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
EP3449879B1 (en) 2011-02-08 2020-09-23 Advanced Bifurcation Systems Inc. System for treating a bifurcation with a fully crimped stent
JP2014511247A (en) 2011-03-03 2014-05-15 ボストン サイエンティフィック サイムド,インコーポレイテッド Low strain high strength stent
WO2012119037A1 (en) 2011-03-03 2012-09-07 Boston Scientific Scimed, Inc. Stent with reduced profile
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
NZ701992A (en) 2012-05-14 2016-03-31 Bard Inc C R Uniformly expandable stent
WO2014066383A1 (en) * 2012-10-22 2014-05-01 The Cleveland Clinic Foundation Apparatus and method for targeting a body tissue
USD723165S1 (en) 2013-03-12 2015-02-24 C. R. Bard, Inc. Stent
US9381103B2 (en) * 2014-10-06 2016-07-05 Abbott Cardiovascular Systems Inc. Stent with elongating struts
US10299948B2 (en) 2014-11-26 2019-05-28 W. L. Gore & Associates, Inc. Balloon expandable endoprosthesis
PL3292842T3 (en) * 2015-05-04 2022-11-21 Suzhou Innomed Medical Device Co., Ltd Intravascular stent
DE102015115279A1 (en) * 2015-09-10 2017-03-16 Bentley Innomed Gmbh Expandable vascular support
US11622872B2 (en) 2016-05-16 2023-04-11 Elixir Medical Corporation Uncaging stent
EP3457985B1 (en) 2016-05-16 2021-02-17 Elixir Medical Corporation Uncaging stent
US10568752B2 (en) 2016-05-25 2020-02-25 W. L. Gore & Associates, Inc. Controlled endoprosthesis balloon expansion
US10238513B2 (en) 2017-07-19 2019-03-26 Abbott Cardiovascular Systems Inc. Intravascular stent
EP3664752A4 (en) 2017-08-11 2021-03-10 Elixir Medical Corporation Uncaging stent

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886062A (en) * 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US5556414A (en) * 1995-03-08 1996-09-17 Wayne State University Composite intraluminal graft
US5569295A (en) * 1993-12-28 1996-10-29 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5591197A (en) * 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
CA2380683C (en) * 1991-10-28 2006-08-08 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5342387A (en) * 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
US5496365A (en) * 1992-07-02 1996-03-05 Sgro; Jean-Claude Autoexpandable vascular endoprosthesis
CA2157575C (en) * 1994-04-01 2000-03-07 Lilip Lau Self-expandable stent and stent-graft and method of using them
EP0679372B1 (en) * 1994-04-25 1999-07-28 Advanced Cardiovascular Systems, Inc. Radiopaque stent markers
US5593442A (en) * 1995-06-05 1997-01-14 Localmed, Inc. Radially expansible and articulated vessel scaffold
US5562697A (en) * 1995-09-18 1996-10-08 William Cook, Europe A/S Self-expanding stent assembly and methods for the manufacture thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886062A (en) * 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US5569295A (en) * 1993-12-28 1996-10-29 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5556414A (en) * 1995-03-08 1996-09-17 Wayne State University Composite intraluminal graft
US5591197A (en) * 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6723118B1 (en) 1997-10-01 2004-04-20 Scimed Life Systems, Inc. Flexible metal wire stent
US6071308A (en) * 1997-10-01 2000-06-06 Boston Scientific Corporation Flexible metal wire stent
US6976994B2 (en) 1997-10-01 2005-12-20 Boston Scientific Scimed, Inc. Flexible metal wire stent
US7160321B2 (en) 1998-03-30 2007-01-09 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US8052734B2 (en) 1998-03-30 2011-11-08 Innovational Holdings, Llc Expandable medical device with beneficial agent delivery mechanism
US7896912B2 (en) 1998-03-30 2011-03-01 Innovational Holdings, Llc Expandable medical device with S-shaped bridging elements
US8052735B2 (en) 1998-03-30 2011-11-08 Innovational Holdings, Llc Expandable medical device with ductile hinges
US8439968B2 (en) 1998-03-30 2013-05-14 Innovational Holdings, Llc Expandable medical device for delivery of beneficial agent
US7279004B2 (en) 1998-03-30 2007-10-09 Innovational Holdings, Llc. Expandable medical device with curved hinge
EP1616534A3 (en) * 1998-04-01 2006-01-25 Quanam Medical Corporation Expandable unit cell and intraluminal stent
USRE44763E1 (en) 1998-04-01 2014-02-11 Boston Scientific Scimed, Inc. Expandable unit cell and intraluminal stent
EP1616534A2 (en) * 1998-04-01 2006-01-18 Quanam Medical Corporation Expandable unit cell and intraluminal stent
WO1999049811A1 (en) * 1998-04-01 1999-10-07 Quanam Medical Corporation Expandable unit cell and intraluminal stent
JP2009050716A (en) * 1998-12-18 2009-03-12 Cook Inc Cannula stent
JP2002532136A (en) * 1998-12-18 2002-10-02 クック インコーポレイティド Cannula tent
US7479127B2 (en) 1999-05-20 2009-01-20 Innovational Holding, Llc Expandable medical device delivery system and method
JP2003500101A (en) * 1999-05-20 2003-01-07 コナー メドシステムズ, インコーポレイテッド Expandable medical device with ductile hinge
JP2003515386A (en) * 1999-12-03 2003-05-07 テラメッド・インコーポレイテッド Endovascular graft system
US8187321B2 (en) 2000-10-16 2012-05-29 Innovational Holdings, Llc Expandable medical device for delivery of beneficial agent
US7850728B2 (en) 2000-10-16 2010-12-14 Innovational Holdings Llc Expandable medical device for delivery of beneficial agent
US7842083B2 (en) 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
US7850727B2 (en) 2001-08-20 2010-12-14 Innovational Holdings, Llc Expandable medical device for delivery of beneficial agent
US8257427B2 (en) 2001-09-11 2012-09-04 J.W. Medical Systems, Ltd. Expandable stent
DE102004045226B4 (en) * 2004-09-17 2008-01-17 Optiray Medizintechnik Gmbh support prosthesis
US8628563B2 (en) 2004-09-17 2014-01-14 Thilo Fliedner Support prosthesis
WO2006029619A1 (en) * 2004-09-17 2006-03-23 Optiray Medizintechnik Gmbh Supporting prosthesis
US9107899B2 (en) 2005-03-03 2015-08-18 Icon Medical Corporation Metal alloys for medical devices
EP2040643A4 (en) * 2006-07-13 2011-08-17 Icon Medical Corp Stent
EP2040643A2 (en) * 2006-07-13 2009-04-01 Icon Medical Corp. Stent
US9034245B2 (en) 2010-03-04 2015-05-19 Icon Medical Corp. Method for forming a tubular medical device
US9855159B2 (en) 2011-03-29 2018-01-02 Terumo Kabushiki Kaisha Stent and stent delivery system
US11779685B2 (en) 2014-06-24 2023-10-10 Mirus Llc Metal alloys for medical devices
US11766506B2 (en) 2016-03-04 2023-09-26 Mirus Llc Stent device for spinal fusion

Also Published As

Publication number Publication date
US5922020A (en) 1999-07-13
AU3808997A (en) 1998-02-25
JP2000516486A (en) 2000-12-12

Similar Documents

Publication Publication Date Title
US5922020A (en) Tubular prosthesis having improved expansion and imaging characteristics
US8109991B2 (en) Endoprosthesis having foot extensions
US7625398B2 (en) Endoprosthesis having foot extensions
EP2364676B1 (en) Endoprosthesis having foot extensions
EP1155664B1 (en) A helical stent having flat ends
US6605110B2 (en) Stent with enhanced bendability and flexibility
EP1503700B1 (en) Endoprosthesis having foot extensions
US6331189B1 (en) Flexible medical stent
RU2211006C2 (en) Intravascular dilating implant with deflector
US7887578B2 (en) Stent having an expandable web structure
US20090024205A1 (en) Radially Expandable Stent
MXPA03008852A (en) Radiopaque intraluminal medical device.
WO2000059405A1 (en) Ladder-type expandable stent
US11701500B2 (en) Method of making drug-elution control sleeve for drug-eluting balloon

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA IL JP KR NZ

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA